Article info
PDFResponse
Privacy, autonomy and direct-to-consumer genetic testing: a response to Vayena
- Correspondence to Kyle van Oosterum, Faculty of Philosophy, Oxford University, Oxford, UK; kyle.vanoosterum{at}philosophy.ox.ac.uk
Citation
Privacy, autonomy and direct-to-consumer genetic testing: a response to Vayena
Publication history
- Received November 8, 2021
- Accepted January 2, 2022
- First published January 6, 2022.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- From proband to provider: is there an obligation to inform genetic relatives of actionable risks discovered through direct-to-consumer genetic testing?
- Direct-to-consumer genomics on the scales of autonomy
- Knowing me, knowing you
- Direct-to-consumer genetic testing
- Direct to consumer genetic testing and the libertarian right to test
- Direct to consumer genetic testing
- Commercial DNA tests and police investigations: a broad bioethical perspective
- Ethics of genetic testing and research in sport: a position statement from the Australian Institute of Sport
- Margaret McCartney: Direct to consumer genetic testing—is all knowledge power?
- Disclosure ‘downunder’: misadventures in Australian genetic privacy law